3 research outputs found
Analysis of the metabolic and epidemiological profile of patients with squamous cell carcinoma of the oral cavity
O carcinoma epidermoide de cavidade oral (CECO) é um dos tumores mais comuns em câncer de cabeça e pescoço, com aproximadamente 300.000 novos casos e 145.000 mortes em todo o mundo. Apesar da intensa pesquisa e dos avanços recentes no diagnóstico e terapia, a taxa de sobrevivência dos pacientes ainda é baixa. Os estudos da metabolômica levaram a uma melhor compreensão do metabolismo do câncer, no seu desenvolvimento e progressão. Essas descobertas possibilitaram a identificação de biomarcadores metabólicos que podem auxiliar na identificação de doenças e tratamentos. O presente estudo buscou três objetivos: (1) Identificar e quantificar os metabólitos plasmáticos em portadores de CECO e em controles, utilizando técnicas de ressonância magnética nuclear (RMN); (2) Comparar a concentração plasmática de metabólitos de pacientes com CECO com a de seus controles estratificados por variáveis clínicas, patológicas, sociodemográficas e características de estilo de vida; (3) Avaliar se as concentrações de metabólitos estão relacionadas com a presença da doença (CECO), ajustadas pelas variáveis epidemiológicas e características de estilo de vida. Para a análise dos metabólitos, amostras de plasma sanguíneo de 47 casos e de 49 controles foram identificadas, quantificadas e comparadas com variáveis clínicas, patológicas, sociodemográficas e características de estilo de vida por meio de análises estatísticas. Os resultados mostram que todos os indivíduos portadores de CECO estiveram expostos em algum momento da vida aos fatores de risco (álcool, tabaco e má higiene bucal). Além disso, as variáveis mostraram interferir na concentração dos metabólitos, estes que apresentaram-se alterados, principalmente os que possuem relação com as vias metabólicas de obtenção de energia, sugerindo que o metabolismo de pacientes com CECO difere dos indivíduos sem a doença (controles)Squamous cell carcinoma of the oral cavity (SCCOC) is one of the most common tumors in head and neck cancer, with approximately 300,000 new cases and 145,000 deaths worldwide each year. Despite intense research and recent advances in diagnosis and therapy, the patient\'s survival rate is still low. Metabolism studies have led to a better understanding of the metabolism of cancer in its development and progression. Theses findings allowed the identification of metabolic biomarkers that may aid to identificate diseases and treatments. This current study aimed at three objectives: (1) To identify and quantify plasma metabolites in SCCOC patients and controls using nuclear magnetic resonance (NMR) techniques; (2) To compare plasma concentration of metabolites of patients with SCCOC and its stratified controls by clinical, pathological, sociodemographics, and lifestyle characteristics; (3) To evaluate whether the metabolic concentrations are related to the presence of SCCOC, adjusted by epidemiological variables and lifestyle characteristics. In order to analyze the metabolites, blood plasma samples from 47 cases and 49 controls were identified, quantified and compared with clinical, pathological, sociodemographic, and lifestyle variables by means of statistical analysis. The results show that all subjects with SCCOC were exposed eventually to risk factors (alcohol consumption, smoking and bad oral hygiene). Furthermore, the variables showed to interfere in the concentration of metabolites, which have been altered, especially those that are related to metabolic pathways of obtaining energy, suggesting that the metabolism of patients with SCCOC differs from the individuals without the disease (controls
Analysis of the metabolic and epidemiological profile of patients with squamous cell carcinoma of the oral cavity
O carcinoma epidermoide de cavidade oral (CECO) é um dos tumores mais comuns em câncer de cabeça e pescoço, com aproximadamente 300.000 novos casos e 145.000 mortes em todo o mundo. Apesar da intensa pesquisa e dos avanços recentes no diagnóstico e terapia, a taxa de sobrevivência dos pacientes ainda é baixa. Os estudos da metabolômica levaram a uma melhor compreensão do metabolismo do câncer, no seu desenvolvimento e progressão. Essas descobertas possibilitaram a identificação de biomarcadores metabólicos que podem auxiliar na identificação de doenças e tratamentos. O presente estudo buscou três objetivos: (1) Identificar e quantificar os metabólitos plasmáticos em portadores de CECO e em controles, utilizando técnicas de ressonância magnética nuclear (RMN); (2) Comparar a concentração plasmática de metabólitos de pacientes com CECO com a de seus controles estratificados por variáveis clínicas, patológicas, sociodemográficas e características de estilo de vida; (3) Avaliar se as concentrações de metabólitos estão relacionadas com a presença da doença (CECO), ajustadas pelas variáveis epidemiológicas e características de estilo de vida. Para a análise dos metabólitos, amostras de plasma sanguíneo de 47 casos e de 49 controles foram identificadas, quantificadas e comparadas com variáveis clínicas, patológicas, sociodemográficas e características de estilo de vida por meio de análises estatísticas. Os resultados mostram que todos os indivíduos portadores de CECO estiveram expostos em algum momento da vida aos fatores de risco (álcool, tabaco e má higiene bucal). Além disso, as variáveis mostraram interferir na concentração dos metabólitos, estes que apresentaram-se alterados, principalmente os que possuem relação com as vias metabólicas de obtenção de energia, sugerindo que o metabolismo de pacientes com CECO difere dos indivíduos sem a doença (controles)Squamous cell carcinoma of the oral cavity (SCCOC) is one of the most common tumors in head and neck cancer, with approximately 300,000 new cases and 145,000 deaths worldwide each year. Despite intense research and recent advances in diagnosis and therapy, the patient\'s survival rate is still low. Metabolism studies have led to a better understanding of the metabolism of cancer in its development and progression. Theses findings allowed the identification of metabolic biomarkers that may aid to identificate diseases and treatments. This current study aimed at three objectives: (1) To identify and quantify plasma metabolites in SCCOC patients and controls using nuclear magnetic resonance (NMR) techniques; (2) To compare plasma concentration of metabolites of patients with SCCOC and its stratified controls by clinical, pathological, sociodemographics, and lifestyle characteristics; (3) To evaluate whether the metabolic concentrations are related to the presence of SCCOC, adjusted by epidemiological variables and lifestyle characteristics. In order to analyze the metabolites, blood plasma samples from 47 cases and 49 controls were identified, quantified and compared with clinical, pathological, sociodemographic, and lifestyle variables by means of statistical analysis. The results show that all subjects with SCCOC were exposed eventually to risk factors (alcohol consumption, smoking and bad oral hygiene). Furthermore, the variables showed to interfere in the concentration of metabolites, which have been altered, especially those that are related to metabolic pathways of obtaining energy, suggesting that the metabolism of patients with SCCOC differs from the individuals without the disease (controls
Plasma metabolomics of oral squamous cell carcinomas based on NMR and MS approaches provides biomarker identification and survival prediction
Abstract Metabolomics has proven to be an important omics approach to understand the molecular pathways underlying the tumour phenotype and to identify new clinically useful markers. The literature on cancer has illustrated the potential of this approach as a diagnostic and prognostic tool. The present study aimed to analyse the plasma metabolic profile of patients with oral squamous cell carcinoma (OSCC) and controls and to compare patients with metastatic and primary tumours at different stages and subsites using nuclear magnetic resonance and mass spectrometry. To our knowledge, this is the only report that compared patients at different stages and subsites and replicates collected in diverse institutions at different times using these methodologies. Our results showed a plasma metabolic OSCC profile suggestive of abnormal ketogenesis, lipogenesis and energy metabolism, which is already present in early phases but is more evident in advanced stages of the disease. Reduced levels of several metabolites were also associated with an unfavorable prognosis. The observed metabolomic alterations may contribute to inflammation, immune response inhibition and tumour growth, and may be explained by four nonexclusive views—differential synthesis, uptake, release, and degradation of metabolites. The interpretation that assimilates these views is the cross talk between neoplastic and normal cells in the tumour microenvironment or in more distant anatomical sites, connected by biofluids, signalling molecules and vesicles. Additional population samples to evaluate the details of these molecular processes may lead to the discovery of new biomarkers and novel strategies for OSCC prevention and treatment